• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Biogen Idec Inc. (BIIB)

    -NasdaqGS
    342.40 Up 1.51(0.44%) Dec 26, 4:00PM EST
    |After Hours : 342.06 Down 0.34 (0.10%) Dec 26, 4:47PM EST
    Add to Portfolio
    Prev Close:340.89
    Open:342.92
    Bid:330.00 x 100
    Ask:N/A
    1y Target Est:378.67
    Beta:0.91
    Next Earnings Date:28-Jan-15BIIB Earnings announcement
    Day's Range:338.02 - 345.55
    52wk Range:270.62 - 361.93
    Volume:1,138,728
    Avg Vol (3m):1,722,130
    Market Cap:80.86B
    P/E (ttm):32.43
    EPS (ttm):10.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 0.44%80.86B
    PFEUp 0.73%199.42B

    Key Statistics

    Forward P/E (1 yr):21.02
    P/S (ttm):8.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :13.53
    Quarterly EPS Est (Dec-14) :3.78
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis (MS), neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback